Literature DB >> 11754909

Serous retinal detachment in patients under systemic corticosteroid treatment.

S Kishi1, O Yoshida, R Matsuoka, Y Kojima.   

Abstract

PURPOSE: To understand the pathophysiology of central serous chorioretinopathy or bullous retinal detachment in patients under systemic corticosteroid treatment. Little is understood about the mechanism of the development of serous retinal detachment.
METHODS: Three patients who had developed central serous chorioretinopathy or bullous retinal detachment during systemic corticosteroid administration were examined by fluorescein angiography and indocyanine green angiography.
RESULTS: Indocyanine green angiography revealed dilated choroidal veins, delayed choroidal filling, intrachoroidal hyperfluorescence, and patchy hypofluorescence at or near the sites of dye leakage examined by fluorescein angiography.
CONCLUSIONS: The primary change caused by central serous chorioretinopathy is thought to occur in the choroid, followed by the breakdown of the outer blood-retinal barrier in the pigment epithelium, resulting in the development of serous retinal detachment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754909     DOI: 10.1016/s0021-5155(01)00428-2

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  3 in total

Review 1.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

2.  Retinal microvasculature alteration in central serous chorioretinopathy.

Authors:  Li Yu; Yi Shao; Yong Chai; Lin-Hong Ye; Qi-Chen Yang; Lei Ye; Qing Yuan; Nan Jiang; Jing-Lin Yi
Journal:  Mol Med Rep       Date:  2017-11-21       Impact factor: 2.952

3.  Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.

Authors:  Felipe T da Silva; Carlos E Hirata; Viviane M Sakata; Edilberto Olivalves; Rony Preti; Sergio L G Pimentel; Andre Gomes; Walter Y Takahashi; Rogerio A Costa; Joyce H Yamamoto
Journal:  BMC Ophthalmol       Date:  2012-08-13       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.